Danco Laboratories will likely ask the Supreme Court to intervene if the 5th Circuit does not at least temporarily block Kacsmaryk’s decision.

Illumina told shareholders that Carl Icahn’s board nominees would “threaten the progress” of the biotech company’s core business.

Evusheld was a key antibody treatment taken by people with weak immune systems as an added layer of protection.

FDA commissioner urges parents not to stockpile children’s flu meds amid shortages